Shin Min-Ho, Choi Nam-Kyu
Division of General Surgery, Department of Hepato-Bilio-Pancreatic Surgery and Transplantation Surgery, Chosun University College of Medicine, Gwangju 61453, South Korea.
World J Clin Cases. 2024 Oct 6;12(28):6187-6194. doi: 10.12998/wjcc.v12.i28.6187.
Renal cell carcinoma (RCC) is more common in patients with autosomal dominant polycystic kidney disease (ADPKD) than in the general population. Diagnosing RCC in ADPKD is challenging due to the presence of multiple renal cysts, often leading to delays and difficulties in distinguishing RCC from cyst infection or hemorrhage.
To analyze the prevalence and characterize the clinical features of RCC in patients with ADPKD undergoing simultaneous bilateral native nephrectomy.
Between May 2017 and April 2024, 19 ADPKD patients undergoing hemodialysis and awaiting kidney transplantation due to end-stage renal disease (ESRD) underwent bilateral nephrectomies in a single center. Parameters such as patient characteristics, intraoperative blood loss, blood transfusion volume, length of hospital stay, and postoperative complications were documented. Pathological findings for RCC were reviewed.
A total of 38 kidneys were excised from 19 patients, with a mean age of 56.8 years and an average hemodialysis duration of 84.2 months. Eight patients underwent open nephrectomies, and 11 underwent hand-assisted laparoscopic nephrectomies. RCC was detected in 15.8% of kidneys, affecting 21.1% of patients. Two patients had multifocal RCC in both kidneys. All RCC cases were pT1 stage, with the largest lesion averaging 16.5 mm in diameter. The average operative duration was 120 minutes, with intraoperative blood loss averaging 184.2 mL. Five patients required blood transfusions. Postoperative complications occurred in five patients, with a mean hospital stay of 17.1 days. The mean follow-up period was 28.1 months.
The prevalence of RCC is higher in patients with ADPKD with ESRD than in those with ESRD alone. Thus, clinicians should be cautious and implement surveillance programs to monitor the development of RCC in patients with ADPKD, particularly those on dialysis.
肾细胞癌(RCC)在常染色体显性多囊肾病(ADPKD)患者中比在普通人群中更常见。由于存在多个肾囊肿,在ADPKD中诊断RCC具有挑战性,这常常导致在区分RCC与囊肿感染或出血方面出现延迟和困难。
分析接受同期双侧自体肾切除术的ADPKD患者中RCC的患病率并描述其临床特征。
在2017年5月至2024年4月期间,19例因终末期肾病(ESRD)接受血液透析并等待肾移植的ADPKD患者在单一中心接受了双侧肾切除术。记录了患者特征、术中失血量、输血量、住院时间和术后并发症等参数。对RCC的病理结果进行了回顾。
共从19例患者身上切除了38个肾脏,平均年龄为56.8岁,平均血液透析时间为84.2个月。8例患者接受了开放性肾切除术,11例接受了手辅助腹腔镜肾切除术。在15.8%的肾脏中检测到RCC,影响了21.1%的患者。2例患者双肾均有多灶性RCC。所有RCC病例均为pT1期,最大病变平均直径为16.5毫米。平均手术时间为120分钟,术中平均失血量为184.2毫升。5例患者需要输血。5例患者发生术后并发症,平均住院时间为17.1天。平均随访期为28.1个月。
患有ESRD的ADPKD患者中RCC的患病率高于单纯患有ESRD的患者。因此,临床医生应谨慎并实施监测计划,以监测ADPKD患者,特别是透析患者中RCC的发展。